Skip to main content
SpringerLink
Log in

Chromogranin A in Human Disease

  • Chapter
Chromogranins

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 482))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Angeletti, R.H., Aardal, S., Serck-Hanssen, G., Gee, P., and Helle, K.B., 1994, Vasoinhibitory activity of synthetic peptides from the amino terminus of the adrenomedullary chromogranin A. Acta Physiol Scand 152: 11–19.

    PubMed  CAS  Google Scholar 

  • Blennow, K., Davidsson, P., Wallin, A., and Ekman, R., 1995, Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer’s disease? Dementia, 6: 306–11.

    PubMed  CAS  Google Scholar 

  • Brekke, J.F., Kirkeleit, J., Lugardon, K., and Helle, K.B., 2000, Vasostatins: vasodilators of bovine resistance arteries. In: Chromogranins: Functional and Clinical Aspects. (K.B. Helle and D. Aunis, eds.). Plenum Publishers, London-New York. pp 239–249.

    Google Scholar 

  • Cohn, D.V., Zangerle, R., Fischer-Colbrie, R., Chu, L.L., Elting, J.J., Hamilton, J.W., and Winkler, H., 1982, Similarity of secretory protein If romparathyroid gland to chromogranin A from adrenal medulla. Proc Nat Acad Sci (USA) 79: 6056–6059.

    CAS  Google Scholar 

  • Corti, A., Ferrari, R., and Ceconi, C., 2000, Chromogranin A and tumor necrosis factor alpha in chronic heart failure. In: Chromogranins: Functional and Clinical Aspects. (K.B. Helle and D. Aunis, eds). Plenum Publishers, London-New York, pp 353–362.

    Google Scholar 

  • Cox, M. E., Deeble, P. D., Lakhani, S., and Parsons, S.J., 1999, Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. CancerRes, 59:3821–3830.

    CAS  Google Scholar 

  • Cubeddu, L.X., OConnor, D.T., and Parmer, R.J., 1995, Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy. J Clin Oncol 13:681–687.

    PubMed  CAS  Google Scholar 

  • Cubeddu, L.X., OConnor, D.T., Hoffmann L, and Parmer, R.J., 1995, Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies. Brit J Cancer 72: 1033–1038.

    PubMed  CAS  Google Scholar 

  • Deftos, L.J., and Abrahamsson, P.A., 1998, Granins and prostate cancer. Urology, 51(5A Suppl):141–145.

    PubMed  CAS  Google Scholar 

  • Gill, B.M., Barbosa, J.A., Hogue-Angeletti, R., Varki, N., and O’Connor, D.T., 1992, Chromogranin A epitopes: clues from synthetic peptides and peptide mapping. Neuropeptides 21:105–118.

    Article  PubMed  CAS  Google Scholar 

  • Helle, K.B., 1966, Some chemical and physical properties of the soluble protein fraction of bovine adrenal chromaffin granules. Mol. Pharmacol 2: 298–310.

    PubMed  CAS  Google Scholar 

  • Hsiao, R.J., Mezger, M.S., and OConnor, D.T., 1990a, Chromogranin A in uremia: progressive retention of immunoreactive fragments. Kidney Intern 37: 955–964.

    CAS  Google Scholar 

  • Hsiao, R.J., Neumann, H.P.H., Parmer, R.J., Barbosa, J.A., and O’Connor, D.T., 1990b, Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution. Am J Med 88: 607–613.

    Article  PubMed  CAS  Google Scholar 

  • Hsiao, R.J., Parmer, R.J., Takiyyuddin, M.A., O’Connor, D.T., 1991, Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine 70:33–45.

    PubMed  CAS  Google Scholar 

  • Hsiao, R.J., Seeger, R.C., Yu, A.L., and OConnor, D.T. 1990c, Chromogranin A in children with neuroblastoma: serum concentration parallels disease stage and predicts survival. J Clin Invest 85: 1555–1559.

    PubMed  CAS  Google Scholar 

  • Kailasam, M.T., Parmer, R.J., Stone, R.A., Shankel, S., Kennedy, B.P., Ziegler, M.G., and O’Connor, D.T., 1995, Factitious pheochromocytoma: novel mimickry by Valsalva maneuver and clues to diagnosis. Am JHypertension 8: 651–655.

    CAS  Google Scholar 

  • Kirchmair, R., Benzer, A., Troger, J., Miller, C., Marksteiner, J., Saria, A., Gasser, R.W., Hogue-Angeletti, R., Fischer-Colbrie, R., and Winkler, H., 1994, Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid. Neuroscience, 63:1179–87.

    Article  PubMed  CAS  Google Scholar 

  • Mahata, S.K., Kozak, C.A., Szpirer, J., Szpirer, C, Modi, W.S., Gerdes, H.-H., Huttner, W.B., and O’Connor, D.T., 1996, Dispersion of chromogranin/secretogranin secretory protein family loci in mammalian genomes. Genomics 33: 135–139.

    Article  PubMed  CAS  Google Scholar 

  • Mahata, S.K., O’Connor, D.T., Mahata, M., Yoo, S.H., Taupenot, L., Wu, H., Gill, B.M., and Partner, R.J., 1997, Novel autocrine feedback control of catecholamine release: a discrete chromogranin A fragment is a non-competitive nicotinic cholinergic antagonist. J Clin Invest 100: 1623–1633.

    Article  PubMed  CAS  Google Scholar 

  • Munoz, D.G., 1991, Chromogranin A-like immunoreactive neurites are major constituents of senile plaques. Lab Invest 64: 826–832.

    PubMed  CAS  Google Scholar 

  • Nanes, M.S., O’Connor, D.T., and Marx, S.J., 1989, Plasma chromogranin A in primary hyperparathyroidism. J Clin Endo Metab 69:950–955.

    CAS  Google Scholar 

  • O’Connor, D.T., 1983, Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum. Reg Peptides 6: 263–280.

    Google Scholar 

  • O’Connor, D.T., 1996, Adrenal medulla, catecholamines and pheochromocytoma. In: Cecil Textbook of Medicine. (JC Bennett, F Plum, eds). W.B. Saunders Publishers, 20th ed, Chapter 204. 2, pp. 1253–1257

    Google Scholar 

  • O’Connor, D.T., and Bemstein, K.N., 1984, Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N EngI JMed 311: 764–770.

    Google Scholar 

  • O’Connor, D.T., and Deftos, L.J., 1986, Secretion of chromogranin A by peptide producing endocrine neoplasms. NEngl JMed 314: 1145–1151.

    Google Scholar 

  • O’Connor, D.T., and Frigon, R.P., 1984, Chromogranin A, the major catecholamine storage vesicle soluble protein: multiple size forms, subcellular storage and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay. JBiol Chem 259: 3237–3247.

    Google Scholar 

  • O’Connor, D.T., Burton, D.G., and Deftos, L.J., 1983 Chromogranin A: Immunohistology reveals its universal occurrence in normal polypeptide hormone producing endocrine glands. Life Sci 33: 1657–1663.

    Google Scholar 

  • O’Connor, D.T., Burton, D.G., and Deftos, L.J., 1983b, Immunoreactive chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues J CIinEndo Metab 57: 1084–1986.

    Google Scholar 

  • O’Connor, D.T., Cervenka, J.H., Stone, R.A., Partner, R.J., Franco-Bourland, R., Madrazo, I., and Langlais, P.J., 1993a, Chromogranin A immunoreactivity in human cerebrospinal flui: Properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease. Neuroscience 56:999–1007.

    Google Scholar 

  • O’Connor, D.T., Insel, P.A., Ziegler, M.G., Hook, V.Y., Smith, D.W., Hamilton, BA, Taylor, P.W., and Parmer, R.J., 2000, Heredity and the Autonomic Nervous System in Human Hypertension. CurrentHypertension Reports 2: 16–22.

    Google Scholar 

  • O’Connor, D.T, Kailasam M.T., and Thal, L.J., 1993b, Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia. NeurobiolAging 14: 267–269.

    Google Scholar 

  • O’Connor, D.T., Klein, R.L., Thureson-Klein, A.K., and Barbosa, J.A., 1991, Chromogranin A: localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve. BrainRes 567:188–196.

    Google Scholar 

  • O’Connor, D.T., Frigon, R.P., and Sokoloff, R.L., 1984, Human chromogranin A: purification and characterization from catecholamine storage vesicles of pheochromocytoma. Hypertension 6: 2–12, 1984.

    Google Scholar 

  • O’Connor, D.T., Pandian, M.R., Carlton, E., Cervenka, J.H., Hsiao, R.J., 1989, Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character ofneoplasia, and assessment ofthe effects oforgan failure. Clin Chem 35:1631–1637

    Google Scholar 

  • O’Connor, D.T., Takiyyuddin, M.A., Printz, M.P., Dinh, T.Q., Barbosa, J.A., Rozansky, D.J., Mahata, S.K., Wu, H., Kennedy, B.P., Ziegler, M.G., Wright, F.A., Schlager, G., and Partner, R.J., 2000, Catecholamine storage vesicle protein expression in genetic hypertension. Blood Pressure. 9: in press.

    Google Scholar 

  • Rao, F., Keiser, H.R., and O’Connor, D.T., 2000, Chromogranin A in malignant pheochromocytoma. Hypertension [in revision).

    Google Scholar 

  • Reaven, G.M., Lithell, H., and Landsberg, L., 1996, Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med, 334:374–81.

    Article  PubMed  CAS  Google Scholar 

  • Sanchez-Margelet, V., Gonzalez-Yanes, C., Santos-Alvarez, J., and Najib, S., 2000, Pancreastatin: biological effects and mechanisms of action. In: Chromogranins: Functional and Clinical Aspects. (KB Helle and D Aunis, eds) Plenum Publishers, London-New York, pp 249–264.

    Google Scholar 

  • Sanchez-Margelet, V., Valle, M., Lobon, J.A., Maldonado, A., Escobar, F., Olivan, J., Perez-Cano, R., and Gobema, R., 1995a, Increased pancreastatin-liked immunoreactivity levels in non-obese patients with essential hypertension. J Hypertension 13:251–258

    Google Scholar 

  • Sanchez-Margelet, V., Valle, M., Lobon, J.A., Maldonado, A., Escobar, F., Olivan, J., Perez-Cano, R., and Gobema, R., 1995b, Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Neuropeptides, 29: 97–101.

    Google Scholar 

  • Sapino, A., Papotti, M., Pietribiasi, F., and Bussolati, G., 1998, Diagnostic cytological features of neuroendocrine differentiated carcinoma of the breast. Virchows Archiv 433: 217–222

    Article  PubMed  CAS  Google Scholar 

  • Shults, C.W., OConnor, D.T., Baird, A., Hill, R., Goetz, C.G., Watts, R.L., Klawans, H.L., Carvey, P.M., Bakay, R.M., Gage, F.H., and U, H.S., 1991, Clinical improvement in Parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid. Exp Neurol 111:276–281.

    Article  PubMed  CAS  Google Scholar 

  • Simon-Chazottes, D., Wu, H.-J., Parmer, R.J., Rozansky, D.J., Szpirer, J., Kurtz, T.W., Szpirer, C., Guenet, J.-L., and OConnor, D.T., 1993, Assignment of the chromogranin A locus to homologous regions on mouse chromosome 12 and rat chromosome 6. Genomics 17:252–255.

    Article  PubMed  CAS  Google Scholar 

  • Simonsson M., Ericksson, S., Hakanson, R., Lind, T., Lonroth, H., Lundell, L., O’Connor, D.T., and Sundler, F., 1988, Endocrine cells in the human oxyntic mucosa: a histochemical study. Scand J Gastroenterol 23: 1089–1099.

    PubMed  CAS  Google Scholar 

  • Stabile, B.E., Howard, T.J., Passaro, E, and O’Connor, D.T., 1990, Source of plasma chromogranin A elevation in gastrinoma patients. Arch Surg 125: 451–453.

    PubMed  CAS  Google Scholar 

  • Stridsberg, M., Hellman, U., Wilander, E., Lundqvist, G., Hellsing, K., and Oberg, K., 1993, Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments. J Endocrinol 139: 329–337.

    Article  PubMed  CAS  Google Scholar 

  • Takiyyuddin, M.A., Cervenka, J.H., Hsiao, R.J., Barbosa, J.A., Partner, R.J., and OConnor D.T., 1990, Chromogranin A: storage and release in hypertension. Hypertension 15: 237–246.

    PubMed  CAS  Google Scholar 

  • Takiyyuddin, M.A., DeNicola, L., Gabbai, F.B., Dinh, T.Q., Kennedy, B., Ziegler, M.G., Sabban, E.L., Parmer, R.J., and OConnor, D.T., 1993, Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension. Hypertension 21: 674–679.

    PubMed  CAS  Google Scholar 

  • Takiyyuddin, M.A., Parmer, R.J., Kailasam, M.T., Cervenka, J.H., Kennedy, B., Ziegler, M.G., Lin, M.-C., Li, J., Grim, C.E., Wright, F.A., and O’Connor, D.T., 1995, Chromogranin A in human hypertension: influence of heredity. Hypertension 26: 213–220.

    PubMed  CAS  Google Scholar 

  • Van Kammen, D.P., Peters, J., Yao, J., Neylan, T., Beuger, M., Pontius, E., and O’Connor, D.T., 1992, CSF chromogranin A-like immunoreactivity in schizophrenia: assessment of clinical and biochemical relationships. Schizophrenia Research 6:31–9.

    Google Scholar 

  • Weiler, R., Steiner, H.J., Fischer-Colbrie, R., Schmid, K.W., and Winkler, H. 1991, Undegraded chromogranin A is present in serum and enters the endocytotic lysosomal pathway in kidney. Histochemistry 96: 395–9.

    Article  PubMed  CAS  Google Scholar 

  • Wu, J.T., Astill, M.E., Liu, G.H., and Stephenson, R.A., 1998, Serum chromogranin A. early detection of hormonal resistance in prostate cancer patients. J Clin Lab Anal 12: 20–25.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Center for Molecular Genetics, University of California, San Diego, California, 921 61-911 I

    Daniel T. O’Connor, Sushil K. Mahata, Laurent Taupenot, Manjula Mahata, Carolyn V. Livsey Taylor, Mala T. Kailasam, Michael G. Ziegler & Robert J. Parmer

  2. Veterans Affairs, San Diego Healthcare System, San Diego, California, 921 61-911 I

    Daniel T. O’Connor, Sushil K. Mahata, Laurent Taupenot, Manjula Mahata, Carolyn V. Livsey Taylor, Mala T. Kailasam, Michael G. Ziegler & Robert J. Parmer

Authors
  1. Daniel T. O’Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sushil K. Mahata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laurent Taupenot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manjula Mahata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carolyn V. Livsey Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mala T. Kailasam
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael G. Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Robert J. Parmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Bergen, Bergen, Norway

    Karen B. Helle

  2. INSERM U338, Centre of Neurochemistry, Strasbourg, France

    Dominique Aunis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

O’Connor, D.T. et al. (2002). Chromogranin A in Human Disease. In: Helle, K.B., Aunis, D. (eds) Chromogranins. Advances in Experimental Medicine and Biology, vol 482. Springer, Boston, MA. https://doi.org/10.1007/0-306-46837-9_31

Download citation

  • DOI: https://doi.org/10.1007/0-306-46837-9_31

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46446-1

  • Online ISBN: 978-0-306-46837-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation